Home  |  Resources  |  Sitemap  |  Contact Us  
Manufacturing Unit
Synergia Bio Sciences’ sophisticated sterile manufacturing facility, spread over 16 acres of lush environs with a built-up area of over 70,000 square feet, is designed to meet the most stringent international standards conforming to the WHO cGMP (current Good Manufacturing Practices). The plant in a quality-integrated environment incorporates state-of-the art Quality Control & Research Laboratories with a built up area of nearly 15,000 square feet. In a continuous endeavour to improve quality in our products and processes, we make significant periodic investments in maintaining and upgrading our facilities. The company’s efforts have been rewarded with several certifications and regulatory approvals.

Certifications and Regulatory Approvals:

U.S. FDA approval
French regulatory approval by AFFSAPS (Agence Française de Sécurité Sanitaire des Produits de Santé)
Columbian regulatory approval by INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos)
Ukrainian regulatory approval by the Ministry of Health of Ukraine
Nigerian regulatory approval by NAFDAC (National Agency for Food and Drug Administration and Control)
Ugandan regulatory approval by NDA (National Drug Authority)
WHO GMP Certificate
ISO 9001 : 2000 Certificate
Plant Capacity:

6.5 million ampoules / month
1.5 million vials / month - small volume parenterals
0.2 million vials / month - large volume parenterals
1.2 million vials / month - Ophthalmic / Nasal
© 2010 Synergy Bio Science Ltd. Home  |  About Us  |  Services  |  Methodology  |  Expertise  |  Manufacturing  |  Resources  |  Careers  |  Site Map  |  Terms of Use  |  Contact Us